INTRODUCTION
One of the short-acting sulfonamides used in combination with pyrimethamine to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infection.
THERAPEUTIC USES
- In urinary tract infection
- Burns
- Toxoplasmosis
SIDE EFFECT
- Anxiety
- Blurred vision
- Coma
- Decrease sexual ability in males
- Depression
- Dizziness
- Fast heartbeat
- Feeling cold
MECHANISM OF ACTION
Sulfadiazine is a competitive inhibitor of the bacterial enzyme dihydropteoate synthetase. This enzyme is needed for the proper processing of para-aminobenzoic acid (PABA) which is essential for folic acid synthesis. The inhibited reaction is necessary in these organisms for the synthesis of folic acid.
DRUG-DRUG INTERACTION
Sulfadiazine+Alogliptin= It may increase the hypoglycemic activities of
Sulfadiazine.
Sulfadiazine+Bosentan= The serum concentration of bosentan can be increased
When it is combined with sulfadiazine.
Sulfadiazine+Carvedilol= The serum concentration of carvedilol can be increased
When it is combined with sulfadiazine.
REFERENCE
Tripathi K.D,"Essentials of medical pharmacology",7th edition,page no.704-705
No comments:
Post a Comment